Intratumoral Injection of PV-001-DV Plus DC in Patients With Melanoma
Clinical trial NCT03990493 · UNKNOWN
Trial details
- NCT number
- NCT03990493
- Sponsor
- PrimeVax Immuno-Oncology Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-01
- Primary completion
- 2024-09-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.